456 Impact of angiotensin II pathway inhibition on tumor response to anti PD(L)1 based therapy

• Ravi Madan,
• Seth Steinberg,
• Jung-Min Lee,
• Marijo Bilusic,
• Fatima Karzai,
• Houssein Abdul Sater,
• Scot Niglio,
• Jason Redman,
• Charalampos Floudas,
• Andrea Apolo

Affiliations

Ravi Madan

Aff2 grid.48336.3a0000000419368075National Cancer Institute Bethesda MD USA

Seth Steinberg

Aff4 Natinal Cancer Institute/Biostatistics and Data Management Section Bethesda MD USA

Jung-Min Lee

Aff1 0000 0004 1936 8075grid.48336.3aWomen’s Malignancies Branch, Center for Cancer ResearchNational Cancer Institute Bethesda MD USA

Marijo Bilusic

NCI, Bethesda, MD, USA

Fatima Karzai

NCI, Bethesda, MD, USA

Houssein Abdul Sater

13National Cancer Institute, Bethesda, MD, USA

Scot Niglio

NCI, Bethesda, MD, USA

Jason Redman

NCI, Bethesda, MD, USA

Charalampos Floudas

NCI, Bethesda, MD, USA

Andrea Apolo

NCI, Bethesda, MD, USA